Latest Pyrroles Stories
Ezetimibe makes atorvastatin more efficient in lowering lipids in men and women age 65 and older.
Pfizer has reported positive findings from a post hoc sub-analysis of the five-year Treating to New Targets study.
Aegerion Pharmaceuticals, a biopharmaceutical company engaged in the treatment of cardiovascular and metabolic disease, has announced positive top-line data from three separate Phase II trials involving its lead cholesterol management compound, AEGR-733, which is a microsomal triglyceride transfer protein inhibitor.
Anthera Pharmaceuticals has reached an agreement with the FDA on a Phase III protocol for varespladib in acute coronary syndrome under the FDA's special protocol assessment procedure.
A new study appearing in the Journal of Empirical Legal Studies was unable to find high quality clinical evidence documenting reduced heart attack risk for women in a primary prevention context. Furthermore, advertising omits label information relevant to women.
Anthera Pharmaceuticals has started the Francis clinical trial designed to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome event.
LONDON (Reuters) - British authorities have found a new batch of counterfeit packs of Pfizer Inc's Lipitor cholesterol pill in the legitimate supply chain, highlighting the risk posed by fake drugs, officials said on Thursday.
Treating diabetics who have signs of heart disease with a high dose of the cholesterol-lowering drug Lipitor (80 mg daily), rather than the normal dose of 10 mg daily, can lower the rate of major cardiovascular events by 25 percent, according to a new report.
NEW YORK (Reuters) - Pfizer Inc. on Monday said its Lipitor cholesterol medicine improved kidney function in patients with heart disease in a large clinical study.
NEW YORK (Reuters Health) - Treatment with Lipitor (atorvastatin), one of the popular cholesterol-lowering "statin" drugs, can help the heart pump better in patients with heart failure, according to a new report.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.